Profile data is unavailable for this security.
About the company
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
- Revenue in SEK (TTM)107.50m
- Net income in SEK-191.44m
- Incorporated--
- Employees78.00
- LocationBonesupport Holding ABScheelevagen 19 ALUND 223 70SwedenSWE
- Phone+46 462865370
- Fax+46 462865371
- Websitehttps://www.bonesupport.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Swedencare AB (publ) | 112.80m | 28.02m | 1.14bn | 32.00 | 40.75 | 9.94 | 38.12 | 10.12 | 1.78 | 1.78 | 7.15 | 7.28 | 0.9036 | 2.88 | 6.43 | 3,760,033.00 | 22.44 | 21.27 | 26.44 | 25.73 | 74.81 | 73.33 | 24.84 | 20.84 | 2.93 | 121.29 | 0.0555 | -- | 15.96 | 40.25 | 37.06 | 197.46 | -- | -- |
| Nordic Nanovector ASA | 0.00 | -386.22m | 1.24bn | 49.00 | -- | 2.92 | -- | -- | -7.07 | -7.07 | 0.00 | 6.98 | 0.00 | -- | -- | 0.00 | -66.08 | -34.38 | -79.97 | -38.09 | -- | -- | -- | -73,984.18 | -- | -- | 0.0269 | -- | -100.00 | -- | -14.96 | -- | 48.77 | -- |
| Photocure ASA | 210.42m | -28.28m | 1.25bn | 71.00 | -- | 7.09 | -- | 5.93 | -1.24 | -1.24 | 9.18 | 7.66 | 0.8665 | 0.912 | 10.25 | 2,809,394.00 | -11.65 | -7.27 | -14.41 | -8.35 | 90.48 | 92.74 | -13.44 | -13.11 | 2.76 | -- | 0.0489 | -- | 20.28 | 16.77 | -5.80 | -- | 7.13 | -- |
| Bergenbio ASA | 11.62m | -196.03m | 1.25bn | 24.00 | -- | 3.72 | -- | 107.44 | -3.39 | -3.39 | 0.2011 | 5.21 | 0.0274 | -- | 0.6831 | 459,041.70 | -46.17 | -- | -50.21 | -- | -- | -- | -1,686.74 | -- | -- | -- | 0.0008 | -- | -- | -- | -5.24 | -- | -- | -- |
| Q linea AB | 1.53m | -149.00m | 1.35bn | 61.00 | -- | 3.09 | -- | 881.39 | -7.81 | -7.81 | 0.0788 | 18.79 | 0.0054 | 272.33 | 71.12 | 28,849.06 | -52.20 | -- | -58.19 | -- | -1,369.39 | -- | -9,745.13 | -- | 11.62 | -74,501.00 | 0.0021 | -- | -28.93 | -- | -89.09 | -- | -- | -- |
| Moberg Pharma AB (publ) | 20.11m | -15.87m | 1.41bn | 16.00 | -- | 1.26 | 65.67 | 70.03 | -0.9011 | 32.42 | 1.14 | 61.66 | 0.0162 | 2.41 | 0.3021 | 543,432.40 | -1.28 | 1.35 | -1.36 | 1.46 | 495.56 | -- | -78.91 | 4.26 | 16.38 | -21.35 | 0.0297 | -- | -98.96 | -50.77 | -349.54 | -- | -- | -- |
| Genovis AB | 43.18m | 4.60m | 1.46bn | 21.00 | 318.33 | 50.41 | 172.54 | 33.90 | 0.0729 | 0.0729 | 0.6844 | 0.4603 | 1.01 | -- | -- | 2,159,149.00 | 10.76 | -53.63 | 13.90 | -73.84 | 63.95 | 0.387 | 10.65 | -68.35 | -- | 7.77 | 0.0919 | -- | 51.17 | 31.14 | 78.48 | -- | -5.05 | -- |
| Orphazyme A/S | 0.00 | -410.55m | 1.47bn | 72.00 | -- | 4.55 | -- | -- | -14.31 | -14.31 | 0.00 | 11.25 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -66.07 | 0.0407 | -- | -- | -- | -81.93 | -- | -- | -- |
| IRLAB Therapeutics AB | 44.00k | -82.61m | 1.51bn | 26.00 | -- | 9.23 | -- | 34,402.86 | -2.04 | -2.04 | 0.0011 | 4.06 | 0.0002 | -- | 0.0055 | 1,760.00 | -36.48 | -- | -40.18 | -- | -- | -- | -187,752.30 | -- | -- | -1,179.16 | 0.00 | -- | -83.49 | -- | -31.79 | -- | -- | -- |
| Bonesupport Holding AB | 107.50m | -191.44m | 1.81bn | 78.00 | -- | 9.39 | -- | 16.86 | -3.72 | -3.72 | 2.09 | 3.72 | 0.3133 | 0.5781 | 5.11 | 1,493,083.00 | -55.79 | -- | -65.92 | -- | 85.37 | -- | -178.08 | -- | 3.31 | -3,171.15 | 0.0581 | -- | -25.27 | -- | -36.89 | -- | -- | -- |
| Orexo AB | 819.20m | 182.40m | 1.88bn | 130.00 | 10.51 | 3.40 | 8.90 | 2.30 | 5.15 | 5.15 | 23.17 | 15.93 | 0.6269 | 0.826 | 2.73 | 6,350,388.00 | 13.96 | -1.44 | 22.67 | -2.10 | 82.62 | 77.80 | 22.27 | -2.28 | 1.91 | -- | 0.4099 | -- | 21.66 | 12.77 | 494.40 | -- | -43.66 | -- |
| Infant Bacterial Therapeutics AB | 0.00 | -40.38m | 2.00bn | 8.00 | -- | 3.77 | -- | -- | -3.60 | -3.60 | 0.00 | 48.86 | 0.00 | -- | -- | 0.00 | -6.99 | -17.29 | -7.09 | -18.00 | -- | -- | -- | -28,727.13 | -- | -806.50 | 0.00 | -- | -100.00 | -- | -12.31 | -- | -- | -- |
| Surgical Science Sweden AB | 69.57m | -4.90m | 2.06bn | 36.00 | -- | 20.59 | 190.24 | 29.58 | -1.01 | -1.01 | 14.30 | 14.86 | 0.722 | 2.82 | 5.28 | 1,880,297.00 | -5.09 | -- | -6.15 | -- | 75.75 | -- | -7.05 | -- | 2.71 | -- | 0.00 | -- | 14.58 | -- | -75.43 | -- | -- | -- |
| Hofseth Biocare ASA | 62.08m | -85.74m | 2.12bn | 28.00 | -- | 36.91 | -- | 34.10 | -0.2819 | -0.2819 | 0.2038 | 0.1669 | 0.3097 | 1.47 | 5.99 | -- | -42.77 | -43.71 | -90.65 | -77.78 | 17.21 | 21.43 | -138.12 | -187.25 | 0.4394 | -81.96 | 0.7145 | -- | -8.29 | -0.7078 | -414.53 | -- | -19.64 | -- |
| Calliditas Therapeutics AB | 138.24m | -35.02m | 2.26bn | 14.00 | -- | 3.12 | -- | 16.35 | -3.21 | -3.21 | 4.68 | 18.72 | 0.3576 | -- | 1.31 | 13,824,300.00 | -9.06 | -- | -10.43 | -- | -- | -- | -25.33 | -- | -- | -20.09 | 0.00 | -- | -- | -- | -52.14 | -- | -- | -- |
Data as of Oct 23 2019. Currency figures normalised to Bonesupport Holding AB's reporting currency: Swedish Krona SEK
39.25%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lundbeckfond Invest A/Sas of 30 Jun 2019 | 4.79m | 9.23% |
| Swedbank Robur Fonder ABas of 30 Jun 2019 | 4.09m | 7.88% |
| Tredje AP-fondenas of 30 Jun 2019 | 4.05m | 7.80% |
| Fj�rde AP-fondenas of 30 Jun 2019 | 2.49m | 4.81% |
| Lancelot Asset Management ABas of 30 Jun 2019 | 1.65m | 3.17% |
| AMF Fonder ABas of 31 Dec 2018 | 1.50m | 2.89% |
| AXA Investment Managers (Paris) SAas of 30 Jun 2019 | 1.01m | 1.95% |
| E. �hman J :or Fonder ABas of 30 Jun 2018 | 300.00k | 0.58% |
| Xact Kapitalf�rvaltning ABas of 30 Sep 2019 | 266.03k | 0.51% |
| SEB Investment Management ABas of 30 Jun 2019 | 222.41k | 0.43% |
More ▼
Data from 31 Dec 2018 - 30 Sep 2019Source: FactSet Research Systems Inc.
